|  | |
| Names | |
|---|---|
| IUPAC name 8-(2,3-Dihydro-1,4-benzodioxin-2-ylmethyl)-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one | |
| Identifiers | |
| 3D model (JSmol) | |
| ChEMBL | |
| ChemSpider | 
 | 
| MeSH | Spiroxatrine | 
| PubChem CID | |
| UNII | |
| CompTox Dashboard (EPA) | |
| 
 | |
| 
 | |
| Properties | |
| C22H25N3O3 | |
| Molar mass | 379.460 g·mol−1 | 
| Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). Infobox references | |
Spiroxatrine is a drug which acts as a selective antagonist at both the 5-HT1A receptor and the α2C adrenergic receptor.[1] It is an analog of spiperone and also has some dopamine antagonist effects.
References
    This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

